Registered entities
Salix Pharmaceuticals Ltd
Reg. No. 1009356United States
Salix Pharmaceuticals, Inc.
Reg. No. 770234925United States
SALIX
Reg. No. 48703003788Latvia
Innovation
83 patent families (46 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Emerging technologies; filing pace slowing. Cited 7,571 times.
| Year | Filings |
|---|---|
| 2015 | 42 |
| 2016 | 37 |
| 2017 | 23 |
| 2018 | 19 |
| 2019 | 17 |
| 2020 | 15 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 2 |
Social engagement
Social engagement: 34.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
5 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 3 | 60% |
| Other / undisclosed | 1 | 20% |
Recent activity
23 Jun 2026
Event
GI ReConnect
12 Jun 2026
Event
Specialty Alliance Annual Meeting
1 Jun 2026
Event
Specialty Alliance Annual Meeting